In October 2019, the FDA approved CINVANTI to be administered as a 130-mg, single-dose regimen on Day 1 for MEC as well as HEC. This eliminates the need for patients to take oral aprepitant on Days 2 or 3. The
Co-administration of CINVANTI with warfarin, a CYP2C9 substrate, may result in a clinically significant decrease in the International Normalized Ratio (INR) of prothrombin time. Monitor the INR in patients on chronic warfarin therapy in the 2-week period, particularly at 7 to 10 days, following...
Co-administration of CINVANTI with warfarin, a CYP2C9 substrate, may result in a clinically significant decrease in the International Normalized Ratio (INR) of prothrombin time. Monitor the INR in patients on chronic warfarin therapy in the 2-week period, particularly at 7 to 10 days, following...
[关键字]:Cinvanti化疗止吐 健康网讯:
CINVANTI(阿瑞)注射式乳剂获批上市 近日,Heron Therapeutics公司宣布,美国食品药品监督管理局(FDA)已批准旗下药品CINVANTI(阿瑞)注射式乳剂上市,在接受高度致吐性癌症化疗的患者中预防和治疗相关的恶心和呕吐。 CINVANTI是一种底物P物质/神经激肽-1(NK1)受体拮抗剂。值得注意的是,解决化疗呕吐的方式主要有两个机制,...
HERON THERAPEUTICS INC生产厂家英文名:HERON THERAPEUTICS INC 原产地英文商品名:CINVANTI 130MG/18ML INJ SDV原产地英文药品名:APREPITANT中文参考商品译名:CINVANTI注射用乳剂 130毫克/18毫升/瓶中文参考药品译名:阿瑞匹坦简介:近日,美国FDA批准抗呕吐新药CINVANTI(aprepitant)注射式乳剂上市,在接受高度致吐性癌症化疗的...
美国上市药品目录集提供Cinvanti的基本信息,包括Cinvanti的申请号209296,申请类型,活性成分Aprepitant,中文名称阿瑞匹坦,申请机构,批准日期等药品信息,更多美国药品Cinvanti的信息查询就在戊戌数据美国上市药品数据库.
HERON THERAPEUTICS INC原产地英文商品名:CINVANTI 130MG/18ML INJ SDV 1/EA原产地英文药品名:APREPITANT中文参考商品译名:CINVANTI注射用乳剂 130毫克/18毫升/瓶 1瓶/盒中文参考药品译名:阿瑞匹坦简介:近日,美国FDA批准抗呕吐新药CINVANTI(aprepitant)注射式乳剂上市,在接受高度致吐性癌症化疗的患者中预防和治疗相关的...
"Cinvanti, delivering the efficacy of aprepitant, but without polysorbate 80, has been an important addition for the prevention of CINV. Notably, data now show that the 2-minute IV push has comparable safety to the 30-minute IV infusion. This approval will enable physicians to leverage the op...
Heron's rationale for the investigation of Cinvanti for the treatment of COVID-19 is based on multiple potential mechanisms for activity. Suppressing the cytokine storm could be a crucial step to prevent the clinical deterioration of patients with COVID-19. Administration...